Dexamethasone-implant for the Treatment of RVO

计划入组 64 人 · 首次发布于 2013 年 1 月 14 日

Fluocinolone Acetonide Implant for Retinal Vein Occlusion (RVO)

计划入组 30 人 · 首次发布于 2008 年 3 月 14 日

Combined Triple Procedure in Retinal Vein Occlusion (RVO)

计划入组 40 人 · 首次发布于 2008 年 12 月 9 日

Valoctocogene roxaparvovec(Roctavian)

RVT-3101

EVO-46141

RDO Pharm.

Rho, Inc.

United States

REVO BIOLOGICS

United States

Chugai's Vabysmo Receives Japanese Approval for Retinal Vein Occlusion Treatment

Annexin Pharmaceuticals Receives UK Approval for Phase 2a Study of ANXV in Diabetic Retinopathy

Roche Canada Secures Public Funding for Vabysmo in Quebec for Retinal Vein Occlusion Treatment